|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 309/15 | |
| C07D 263/57 | |||
| A61K 31/185 | |||
| A61K 31/423 | |||
| A61P 3/10 |
| (11) | Number of the document | 3153501 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16198552.8 |
| Date of filing the European patent application | 2009-08-13 | |
| (97) | Date of publication of the European application | 2017-04-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 88697 P | 2008-08-13 | US |
| (72) |
GOMEZ-GALENO, Jorge E., US
HECKER, Scott J., US
DANG, Qun, US
REDDY, Mali Venkat, US
SUN, Zhili, US
GROTE, Matthew P., US
NGUYEN, Thanh Huu, US
LEMUS, Robert Huerta, US
LI, Haiqing, US
|
| (73) |
Metabasis Therapeutics, Inc.,
3911 Sorrento Valley Boulevard, Suite 110, San Diego, CA 92121,
US
|
| (54) | GLUCAGON ANTAGONISTS |
| GLUCAGON ANTAGONISTS |